1. Human cytochrome P450 enzymes 5–51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition – toxic effects and benefits
    Slobodan P. Rendic et al, 2018, Drug Metabolism Reviews CrossRef
  2. Insulin/IGF-1R, SIRT1, and FOXOs Pathways—An Intriguing Interaction Platform for Bone and Osteosarcoma
    Consolato Sergi et al, 2019, Frontiers in Endocrinology CrossRef
  3. Regulation of aromatase in cancer
    Deborah Molehin et al, 2021, Molecular and Cellular Biochemistry CrossRef
  4. Function of microRNA‑141 in human breast cancer through cytotoxic CD4+ T cells regulated by MAP4K4 expression
    Qing Zhang et al, 2018, Molecular Medicine Reports CrossRef
  5. Leptin stimulates aromatase in the growth plate: limiting catch-up growth efficiency
    Majdi Masarwi et al, 2018, Journal of Endocrinology CrossRef
  6. Systems biology–based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma
    Lei Huang et al, 2018, Science Translational Medicine CrossRef
  7. A candidate pathogenic gene, zinc finger gene 217 ( ZNF 217 ), may contribute to polycystic ovary syndrome through prostaglandin E2
    Junyu Zhai et al, 2020, Acta Obstetricia et Gynecologica Scandinavica CrossRef
  8. Obesity and breast cancer – Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue
    Céline Gérard et al, 2018, Molecular and Cellular Endocrinology CrossRef
  9. A review and update for registered clinical studies of stem cells for non-tumorous and non-hematological diseases
    Jianhua Chen et al, 2021, Regenerative Therapy CrossRef